CLS Participates in Expert COVID-19 Panel
Expert Panel: COVID Vaccines and Drug Trials, Plus the Third Spike in COVID Cases
Thursday, October 29, 3:00pm – 4:00pm EDT
Panelists will discuss progress with the vaccines and drug trials, as well as the epidemiology of the rising rate of COVID cases in the U.S.
Coriell Life Sciences’ Jeffrey Shaman notes, “Pharmacogenomics is not a silver bullet. It’s a helping hand for doctors to help zero in on treatment options. We’re now leveraging PGx to offer a variety of COVID-related services, including data interpretation and reporting services for SARS-CoV-2 detection and precision prescribing for COVID-19 treatment through genetics. CLS’ medication safety pharmacogenomics report delivers measurable benefits, including potentially quicker recovery, reduced healthcare costs, and simplified decision-making.”
Panelists:
Dr. Edward Jones-Lopez – Assistant Professor & Infectious Diseases Specialist at Keck Medicine of USC & Investigator on the AstraZenea vaccine trial
Perry N. Halkitis, Ph.D., MS, MPH – Dean of the Rutgers School of Public Health
Dr. Stephen Spector – Professor, Pediatrics at UC San Diego & PI on the UCSD arm of the Moderna trial
Sean Diehl, Ph.D.- Associate Professor at The University of Vermont Larner College of Medicine & Published Serology Study
Robert Salata, MD – Infectious Disease Specialist and Chairman of the Department of Medicine at University Hospitals Cleveland Medical Center & Participating in the study of the Phase 2/3 global study by Pfizer Inc
Shobha Swaminathan, MD – Associate Professor and the principal investigator for the Moderna trial at the Rutgers New Jersey Medical School
Jeffrey A. Shaman, PhD, MS – Chief Science Officer at Coriell Life Sciences